RE:RE:RE:Way Forwardif our analyst maintains his forecast I would see that as a good sign. Thereby giving Stage the benefit of the doubt in getting the Avrt program up and running. Aristotle actually has been somewhat in action over the past few months with patients being placed in queue on the waitlist while Care and Stage get Avrt ready. Its just the flow of rev that hasn't started until now. But like you say a little guidance over the near term would be nice to see.